Both in Biotechnology
Caribou Biosciences vs Pelthos Therapeutics
Over the past year CRBU returned −81.1% and PTHS returned −68.5%; their daily moves had a correlation of 0.17.
CRBU −81.1% PTHS −68.5%Growth of $1, one year, split-adjusted
| Metric | CRBU | PTHS |
|---|---|---|
| Price | $0.4594 | $10.78 |
| Market cap | $49.3M | $42.4M |
| Today | +4.43% | −6.42% |
| 1 month | −61.4% | −47.4% |
| 6 months | −76.2% | −57.6% |
| Year to date | −71.1% | −65.2% |
| 1 year | −81.0% | — |
| Revenue growth (YoY) | −43.8% | — |
| Gross margin | 100.0% | 76.9% |
| Net margin | −1619.9% | −150.1% |
| P/E (TTM) | — | — |
| Price / sales | 4.9× | 1.0× |
| Net cash | $112.3M | -$45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 146.4% | 140.4% |
| Short % of float | 13.5% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).